Hyperfine【HYPR】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.9199

買値

0.8403

売値

1.05

出来高

142,486

0.82 日の範囲 0.89

0.7613 52 週間の範囲 1.45

時価総額

66.806M

前日終値

0.889

始値

0.89

時刻

200

0.9199

(formt)

最終取引時間

財務取引量

US$ 120,291

VWAP

0.844231

平均取引量 (3 か月)

114,979

発行済株式数

72,622,629

配当利回り

PER

-1.46

1 株当たり利益 (EPS)

-0.61

歳入

11.03M

純利益

-44.24M

Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to... Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings. 詳細を表示

セクター

Electromedical Apparatus

業界

Blank Checks

ウェブサイト

hyperfine.io

本社

Wilmington, Delaware, USA

設立

2021

Hyperfine Inc is listed in the Electromedical Apparatus sector of the ナスダック市場 with ticker HYPR. The last closing price for Hyperfine was US$0.89. Over the last year, Hyperfine shares have traded in a share price range of US$ 0.7613 to US$ 1.45.

Hyperfine currently has 72,622,629 shares in issue. The market capitalisation of Hyperfine is US$64.56 million. Hyperfine has a price to earnings ratio (PE ratio) of -1.46.

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Hyperfine, Inc. Reports Third Quarter 2024 Financial Results

GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared...

Hyperfine Announces European Launch with CE Approval

CE approval of the latest generation Swoop® system software is a significant milestone in Hyperfine’s international strategy, allowing broader European commercial expansion. Hyperfine, Inc...

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality

Today’s presentation at CTAD, a leading international Alzheimer's conference, expands research supporting the value of ultra-low-field MRI in monitoring amyloid-related imaging abnormalities...

Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the...

Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation

The SAFE MRI ECMO study evaluated the use of ultra-low-field portable MR imaging on ICU patients undergoing extracorporeal membrane oxygenation (ECMO) with an elevated risk of acute brain injury...

Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care

The Swoop® Portable MR Imaging® system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke care Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking...

Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0801	-8.01	1	1	0.8483	180393	0.89236508	CS
4	-0.0601	-6.13265306122	0.98	1.05	0.8483	86953	0.93403198	CS
12	-0.1401	-13.2169811321	1.06	1.24	0.8483	114979	1.01072487	CS
26	0.0069	0.755750273823	0.913	1.266	0.8	117561	1.01752041	CS
52	-0.3901	-29.7786259542	1.31	1.45	0.7613	102128	1.0351904	CS
156	-10.9102	-92.224072493	11.8301	16.61	0.68	301321	1.78381799	CS
260	-10.9102	-92.224072493	11.8301	16.61	0.68	301321	1.78381799	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M